The OBRI is excited to share our latest publications:
- Frailty and risk of osteoporotic fractures in patients with rheumatoid arthritis: Data from the Ontario Biologics Research Initiative.
- Impact of Concomitant Use of Disease Modifying Anti-Rheumatic Drugs and Methotrexate Administration Route on Durability of Biologic Treatment in Rheumatoid Arthritis: Results from The Ontario Best Practices Research Initiative (OBRI).
- Impact of residential area on the management of rheumatoid arthritis patients initiating their first biologic DMARD; Results from the Ontario Best Practices Research Initiative (OBRI).